Ethics of the first clinical trials in regenerative medicine for transplantation
The BRAVƎ project will participate in an international workshop on the challenges of new applications in bioengineering and regenerative medicine that are reaching the clinic.
The BRAVƎ project will participate in an international workshop to discuss the challenges of new applications in bioengineering and regenerative medicine that are reaching clinical practice. Entitled ‘Ethics of early clinical trials in regenerative medicine in transplantation’, the meeting will bring together various experts in the fields of regenerative medicine and ethics to assess and discuss issues such as the certification of good practices in conducting clinical trials in humans for a safe and responsible application of bioartificial organs or bioprinted tissues.
At the meeting, in addition to a plenary session and a round table, several projects on applications in regenerative medicine will be presented and a round table discussion will be held. The research to be presented are projects funded by the European Union (Horizon 2020) based on the development of new knowledge in regenerative medicine for translational application. Dr. Manuel Mazo, researcher at the Cima University of Navarra and partner of the BRAVƎ project, will present the BRAVƎ progress in cardiac regeneration.
The University of Geneva is organizing this meeting through its VANGUARD project, a research project that aims to develop a bioartificial pancreas for the treatment of type 1 diabetes.
The workshop will take place tomorrow, February 3, in virtual format from 16h to 18h. (CET) and is open to the public.
More information and registration in this link